{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:53:59Z","timestamp":1768535639202,"version":"3.49.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305487\/2015-9"],"award-info":[{"award-number":["305487\/2015-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Bloodstream infections (BSI) caused by Candida species are the fourth cause of healthcare associated infections worldwide. Non-albicans Candida species emerged in the last decades as agents of serious diseases. In this study, clinical and microbiological aspects of six patients with BSI due to the Meyerozyma (Candida) guilliermondii species complex from an oncology reference center in Brazil, were evaluated. To describe demographic and clinical characteristics, medical records of the patients were reviewed. Molecular identification of the isolates was performed by ITS1-5.8S-ITS2 region sequencing. Antifungal susceptibility was evaluated by the EUCAST method and the minimal inhibitory concentrations (MIC) assessed according to the epidemiological cutoff values. Virulence associated phenotypes of the isolates were also studied. Ten isolates from the six patients were evaluated. Five of them were identified as Meyerozyma guilliermondii and the others as Meyerozyma caribbica. One patient was infected with two M. caribbica isolates with different genetic backgrounds. High MICs were observed for fluconazole and echinocandins. Non-wild type isolates to voriconazole appeared in one patient previously treated with this azole. Additionally, two patients survived, despite infected with non-wild type strains for fluconazole and treated with this drug. All isolates produced hemolysin, which was not associated with a poor prognosis, and none produced phospholipases. Aspartic proteases, phytase, and esterase were detected in a few isolates. This study shows the reduced antifungal susceptibility and a variable production of virulence-related enzymes by Meyerozyma spp. In addition, it highlights the poor prognosis of neutropenic patients with BSI caused by this emerging species complex.<\/jats:p><\/jats:sec><jats:sec><jats:title>Lay Abstract<\/jats:title><jats:p>Our manuscript describes demographic, clinical and microbiological characteristics of patients with bloodstream infection by the Meyerozyma guilliermondii species complex at a reference center in oncology in Brazil.<\/jats:p><\/jats:sec>","DOI":"10.1093\/mmy\/myaa044","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T03:26:22Z","timestamp":1589340382000},"page":"235-243","source":"Crossref","is-referenced-by-count":23,"title":["A case-series of bloodstream infections caused by the<i>Meyerozyma guilliermondii<\/i>species complex at a reference center of oncology in Brazil"],"prefix":"10.1093","volume":"59","author":[{"given":"Alessandra Leal Silva","family":"Chaves","sequence":"first","affiliation":[{"name":"Clinical Pathology Laboratory, HCI, National Cancer Institute, Rio de Janeiro, Brazil"},{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Trilles","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Machado","family":"Alves","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena Galdino","family":"Figueiredo-Carvalho","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-678X","authenticated-orcid":false,"given":"F\u00e1bio","family":"Brito-Santos","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena Alves","family":"Coelho","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ianick S","family":"Martins","sequence":"additional","affiliation":[{"name":"Nosocomial Infection Surveillance and Control Program, National Cancer Institute, Rio de Janeiro, Brazil"},{"name":"Medical School of Universidade Federal Fluminense, Niter\u00f3i, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-6058","authenticated-orcid":false,"given":"Rodrigo","family":"Almeida-Paes","sequence":"additional","affiliation":[{"name":"Mycology Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"2021030816512480900_bib1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"2021030816512480900_bib2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jac\/dkx045","article-title":"Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002--14)","volume":"72","author":"Bretagne","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021030816512480900_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/mmycol\/myu016","article-title":"Uncommon opportunistic yeast bloodstream infections from Qatar","volume":"52","author":"Taj-Aldeen","year":"2014","journal-title":"Med Mycol"},{"key":"2021030816512480900_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1534\/g3.117.300316","article-title":"The genomes of four Meyerozyma caribbica isolates and novel insights into the Meyerozyma guilliermondii species complex","volume":"8","author":"de Marco","year":"2018","journal-title":"G3 Genes, Genomes, Genet"},{"key":"2021030816512480900_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1439-0507.2010.01960.x","article-title":"What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast","volume":"54","author":"Savini","year":"2011","journal-title":"Mycoses"},{"key":"2021030816512480900_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.femsyr.2004.10.008","article-title":"Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov","volume":"5","author":"Vaughan-Martini","year":"2005","journal-title":"FEMS Yeast Res"},{"key":"2021030816512480900_bib7","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1099\/ijsem.0.002232","article-title":"Meyerozyma amylolytica sp. nov. from temperate deciduous trees and the transfer of five Candida species to the genus Meyerozyma","volume":"67","author":"Yurkov","year":"2017","journal-title":"Int J Syst Evol Microbiol"},{"key":"2021030816512480900_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.01889-08","article-title":"Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates","volume":"47","author":"Lockhart","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/mmy\/myy038","article-title":"et al. Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina","volume":"57","author":"Taverna","year":"2019","journal-title":"Med Mycol"},{"key":"2021030816512480900_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/mmy\/myv009","article-title":"Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients","volume":"53","author":"Montoya","year":"2015","journal-title":"Med Mycol"},{"key":"2021030816512480900_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13693786.2012.745953","article-title":"Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples","volume":"51","author":"Tosun","year":"2013","journal-title":"Med Mycol"},{"key":"2021030816512480900_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00203-019-01684-2","article-title":"In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts","volume":"201","author":"Montoya","year":"2019","journal-title":"Arch Microbiol"},{"key":"2021030816512480900_bib13","volume-title":"Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection)","author":"CDC","year":"2020"},{"key":"2021030816512480900_bib14","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021030816512480900_bib15","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1128\/JCM.43.12.6194-6196.2005","article-title":"PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast","volume":"43","author":"Alcoba-Fl\u00f3rez","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib16","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"2021030816512480900_bib17","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST definitive document E.DEF 7.3.1. method for the determination of broth dilution minimum Inhibitory concentrations of antifungal agents for yeasts","volume":"18","author":"Arendrup MC","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021030816512480900_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/1567-1364.12092","article-title":"Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex","volume":"13","author":"Abi-Chacra","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"2021030816512480900_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00362178285380031","article-title":"Plate method for detection of phospholipase activity in Candida albicans","volume":"20","author":"Price","year":"1982","journal-title":"Med Mycol"},{"key":"2021030816512480900_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/AEM.02077-08","article-title":"Production of pyomelanin, a second type of melanin, via the tyrosine degradation pathway in Aspergillus fumigatus","volume":"75","author":"Schmaler-Ripcke","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"2021030816512480900_bib21","doi-asserted-by":"crossref","first-page":"e00099","DOI":"10.1128\/AAC.00099-17","article-title":"Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia","volume":"61","author":"Marcos-Zambrano","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021030816512480900_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/S10267-009-0011-5","article-title":"Phylogenetic analysis of ascomycete yeasts that form coenzyme Q-9 and the proposal of the new genera Babjeviella, Meyerozyma, Millerozyma, Priceomyces, and Scheffersomyces","volume":"51","author":"Kurtzman","year":"2010","journal-title":"Mycoscience"},{"key":"2021030816512480900_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1567-1364.12006","article-title":"Relationships among genera of the Saccharomycotina (Ascomycota) from multigene phylogenetic analysis of type species","volume":"13","author":"Kurtzman","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"2021030816512480900_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3767\/003158515X689135","article-title":"One fungus, which genes? Development and assessment of universal primers for potential secondary fungal DNA barcodes","volume":"35","author":"Stielow","year":"2015","journal-title":"Persoonia"},{"key":"2021030816512480900_bib25","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1117018109","article-title":"The internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Fungal Barcoding Consortium","volume":"109","author":"Schoch","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021030816512480900_bib26","doi-asserted-by":"crossref","first-page":"250408","DOI":"10.1155\/2014\/250408","article-title":"Misidentification of Candida guilliermondii as C. famata among strains isolated from blood cultures by the VITEK 2 system","volume":"2014","author":"Kim","year":"2014","journal-title":"Biomed Res Int"},{"key":"2021030816512480900_bib27","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.4014\/jmb.1609.09012","article-title":"Identification of uncommon Candida species using commercial identification systems","volume":"26","author":"Kim","year":"2016","journal-title":"J Microbiol Biotechnol"},{"key":"2021030816512480900_bib28","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1128\/JCM.01253-10","article-title":"Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates","volume":"49","author":"Meletiadis","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021030816512480900_bib30","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1128\/AAC.02670-14","article-title":"Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center","volume":"58","author":"Marcos-Zambrano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021030816512480900_bib31","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JCM.00865-06","article-title":"Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12879-016-1825-3","article-title":"Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study","volume":"16","author":"van der Geest","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2021030816512480900_bib33","doi-asserted-by":"crossref","first-page":"e12922","DOI":"10.1111\/tid.12922","article-title":"Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis","volume":"20","author":"Nakazawa","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2021030816512480900_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/JCM.02366-12","article-title":"Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in S\u00e3o Paulo, Brazil","volume":"51","author":"Magri","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1462-5822.2004.00439.x","article-title":"Candida albicans proteinases and host\/pathogen interactions","volume":"6","author":"Naglik","year":"2004","journal-title":"Cell Microbiol"},{"key":"2021030816512480900_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tim.2011.02.003","article-title":"Adherence and biofilm formation of non-Candida albicans Candida species","volume":"19","author":"Silva","year":"2011","journal-title":"Trends Microbiol"},{"key":"2021030816512480900_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J Med Microbiol"},{"key":"2021030816512480900_bib38","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1172\/JCI63239","article-title":"Fungal antioxidant pathways promote survival against neutrophils during infection","volume":"122","author":"Leal","year":"2012","journal-title":"J Clin Invest"},{"key":"2021030816512480900_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/genes10010042","article-title":"Stress-tolerant yeasts: opportunistic pathogenicity versus biocontrol potential","volume":"10","author":"Zajc","year":"2019","journal-title":"Genes"},{"key":"2021030816512480900_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8952878","article-title":"Relationship between the antifungal susceptibility profile and the production of virulence-related hydrolytic enzymes in Brazilian clinical strains of Candida glabrata","volume":"2017","author":"Figueiredo-Carvalho","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2021030816512480900_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mycmed.2019.08.001","article-title":"Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures","volume":"29","author":"Sriphannam","year":"2019","journal-title":"J Mycol Med"},{"key":"2021030816512480900_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/456878","article-title":"Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile","volume":"2014","author":"Deorukhkar","year":"2014","journal-title":"Int J Microbiol"},{"key":"2021030816512480900_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01686-12","article-title":"Candida guilliermondii and other species of Candida misidentified as Candida famata: Assessment by Vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs","volume":"51","author":"Castanheira","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021030816512480900_bib44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/mic.0.28626-0","article-title":"Multiple gene genealogical analyses suggest divergence and recent clonal dispersal in the opportunistic human pathogen Candida guilliermondii","volume":"152","author":"Lan","year":"2006","journal-title":"Microbiology"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/3\/235\/36330131\/myaa044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/3\/235\/36330131\/myaa044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:26:15Z","timestamp":1696119975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/3\/235\/5851461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2021,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaa044","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,6,4]]}}}